Effect of different stabilizers on acceptability and shelfstability of soy-yoghurt

The effect of cassava starch and corn starch on the consumers` acceptability and shelf- stability of soyyoghurt was investigated. Three batches of soy-yoghurt were prepared using corn starch, cassavastarch and gelatin as stabilizers, while the fourth batch served as control. All the batches were organoleptically evaluated and stored at 6 ± 2oC for 16 days and were subjected to physical examinationand chemical analyses such as pH, titratable acidity (TTA) and microbial counts. All the stabilizers prevent whey separation. A putrid/offensive odour developed in all yoghurt samples from the 8th day of storage; while gas production was observed in all stabilized soy-yoghurt samples. For both pH and TTA, there was significant difference (

Chronic Diseases in North-West Tanzania and Southern Uganda. Public Perceptions of Terminologies, Aetiologies, Symptoms and Preferred Management

Research outputs produced to support a quantitative population survey, quantitative health facility survey, focus groups and in-depth interviews performed by the projec

European research priorities for intracerebral haemorrhage

Over 2 million people are affected by intracerebral haemorrhage (ICH) worldwide every year, one third of them dying within 1 month, and many survivors being left with permanent disability. Unlike most other stroke types, the incidence, morbidity and mortality of ICH have not declined over time. No standardised diagnostic workup for the detection of the various underlying causes of ICH currently exists, and the evidence for medical or surgical therapeutic interventions remains limited. A dedicated European research programme for ICH is needed to identify ways to reduce the burden of ICH-related death and disability. The European Research Network on Intracerebral Haemorrhage EURONICH is a multidisciplinary academic research collaboration that has been established to define current research priorities and to conduct large clinical studies on all aspects of ICH. Copyright (C) 2011 S. Karger AG, Base

An Estimate of the Incidence and Prevalence of Stroke in Africa:A Systematic Review and Meta-Analysis

Background: Stroke is increasingly becoming a challenging public health issue in Africa, and the non-availability of data has limited research output and consequently the response to this burden. This study aimed to estimate the incidence and prevalence of stroke in Africa in 2009 towards improved policy response and management of the disease in the region. Methods: A systematic search of Medline, EMBASE and Global Health for original population-based or hospital-based studies on stroke was conducted. A random effect meta-analysis was conducted on crude stroke incidence and prevalence rates, and a meta-regression-like epidemiological model was applied on all data points. The fitted curve generated from the model was used to estimate incident cases of stroke and number of stroke survivors in Africa at midpoints of the United Nation population 5-year age groups for the year 2009. Results: The literature search yielded a total of 1227 studies. 19 studies from 10 African countries were selected. 483 thousand new stroke cases among people aged 15 years or more were estimated in Africa in 2009, equivalent to 81.2 (13.2– 94.9)/100,000 person years. A total of 1.89 million stroke survivors among people aged 15 years or more were estimated in Africa in 2009, with a prevalence of 317.3 (314.0–748.2)/100000 population. Comparable figures for the year 2013 based on the same rates would amount to 535 thousand (87.0–625.3) new stroke cases and 2.09 million (2.06–4.93) stroke survivors, suggesting an increase of 10.8% and 9.6% of incident stroke cases and stroke survivors respectively, attributable to population growth and ageing between 2009 and 2013. Conclusion: The findings of this review suggest the burden of stroke in Africa is high and still increasing. There is need for more research on stroke and other vascular risk factors towards instituting appropriate policy, and effective preventive and management measures

Vitamin B12 deficiency presenting with Myeloneuropathy

The neurologic manifestations of vitamin B12 deficiency, although uncommon, are the result of its effects on the brain, optic nerves, peripheral nerves, and spinal cord. Myeloneuropathy, resulting in sensory disturbances, weakness, and spasticity, is known as subacute combined degeneration and primarily involves the dorsal, and lateral spinal columns as well as the peripheral nerves. Subacute combined degeneration is treatable and the symptoms are potentially reversible if detected at an early stage. We present the clinical as well as the laboratory findings in a patient with subacute combined degeneration who had resolution of the clinical neurological manifestations with B12 therapy

Acute Stroke as the first manifestation of Systemic Lupus Erythematosus:A case report and review of the literature

Systemic lupus erythematosus (SLE) is an autoimmune, multisystem disease that is characterized by a bewildering array of antibodies. Central nervous system manifestations of SLE are highly diverse and often have major prognostic consequences, accounting for 15% of cases. It is a known cause of ‘stroke in the young’ especially in the female population. We present the case of a 17-year old female, who presented with acute ischemic stroke as the first presentation of systemic lupus erythematosus. The report is presented to heighten the index of suspicion of SLE, in young patients presenting with acute ischemic stroke, in our environment. Key words: Systemic lupus erythematosus, Acute ischemic stroke, Index, Suspicio

Rhematological manifestations of HIV infections among Nigerians: case reports and literature

No Abstract. Nigerian Medical Practitioner Vol. 47(6) 2005: 117-12

Repeat Stroke Associated with ‘Migraine with Aura’ and Middle Cerebral Artery Stenosis

We present a 21 year-old female, known migraineur, who presented with visual aura followed by throbbing left hemicranial headache, associated with sudden onset of weakness of the right side of the body and moderate to severe pains on the paretic limb (mixed lacuna stroke), three days after the onset of headache. She had a similar episode about 12 months prior to the present ictus. Findings on examination revealed essentially, right spastic hemiparesis with dysaesthesia and subtle right facial paresis. Brain MRI (magnetic resonance imaging) was normal, while MRA (magnetic resonance angiography) revealed middle cerebral artery (M2) stenosis. She was managed with aspirin, propranolol, amitriptyline and physiotherapy on which she made steady progress